A new study recently published by the New England Journal of Medicine found that women at high risk for preterm preeclampsia who took aspirin were less likely to develop the condition than women who were given a placebo.
Women from 13 different hospitals in seven different countries, who had been identified in their first trimesters as high risk for developing preeclampsia, were randomly prescribed either 150 mg of aspirin or a placebo pill.
In this double blind, prospective study, the aspirin or placebo were administered from 11 to 14 weeks of gestation until 36 weeks in women who were at high risk for preeclampsia.
Study results found that 1.6 percent of the women taking the 150 mg dose of aspirin developed preterm preeclampsia, while 4.3 percent of the women taking the placebo developed the life-threatening disorder.
Why it Matters: Preeclampsia is a critical contributing factor to the loss of mothers and babies during childbirth. As maternal mortality rates continue to rise in the United States, there is increased pressure to find effective treatments for women who are at-risk for preeclampsia. This study is the largest of its kind, including 1,776 randomly assigned women from seven different countries. The study also used the European dose of 150 mg, which is almost twice the United States recommended dose of 81 mg. This helps narrow down the effective dose to prescribe and at which point in gestation beginning an aspirin regimen is helpful.
A Call-to-Action to Accelerate Development and Adoption of Biomarkers
Preeclampsia strikes fast. We have heard too many stories of moms who felt like something was wrong, but didn’t have a blood pressure monitor at home, were far from a pharmacy and hours away fro...
The Need As many as one in twelve pregnancies is affected by hypertension in its most dangerous form – preeclampsia. In some regions of the country 15-20% of pregnancies are affected. The curre...
Do not let the fear of contracting COVID-19 virus keep you away from getting the care you need for preeclampsia signs and symptoms. NOT going to the doctor or hospital if you have signs of p...
On April 16, a briefing for U.S. Congressional staff offered insights about how maternity care is being provided in the midst of the COVID pandemic. We joined a number of maternal health organizations...
How to Handle Prenatal and Postpartum Appointments, From Home Your doctor or midwife has asked you to use telehealth for some of your check-ups. That means using your smart phone camera or just a reg...
What is AFLP? Acute Fatty Liver of Pregnancy (AFLP) is a relatively rare disorder that happens only during human pregnancy. It affects an estimated one in 10,000 to 20,000 pregnancies every year (&as...
Data shows the continued critical need for all pregnant women, regardless of trimester, to receive the influenza vaccination, according to an updated Committee Opinion released by the American Colle...
By Eleni Z. Tsigas, Executive Director Reporting from The Pregnancy Meeting™ We spent last week in New Orleans at the Society for Maternal-Fetal Medicine annual meeting, awaiting the results o...